<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">pmed</journal-id><journal-title>PLoS Medicine</journal-title><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0030520</article-id><article-id pub-id-type="publisher-id">06-PLME-RA-0450R2</article-id><article-id pub-id-type="sici">plme-03-12-24</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics</subject><subject>Obstetrics</subject><subject>Public Health and Epidemiology</subject><subject>Women's Health</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>Obstetrics</subject><subject>Genetics</subject><subject>Epidemiology</subject></subj-group></article-categories><title-group><article-title>Angiotensin-Converting Enzyme I/D Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias</article-title><alt-title alt-title-type="running-head">ACE Polymorphisms and Preeclampsia</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Serrano</surname><given-names>Norma C</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref ref-type="corresp" rid="cor1">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>D&#x000ed;az</surname><given-names>Luis A</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e1;ez</surname><given-names>Maria C</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Mesa</surname><given-names>Clara M</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Cifuentes</surname><given-names>Rodrigo</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Monterrosa</surname><given-names>Alvaro</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>Adriana</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Smeeth</surname><given-names>Liam</given-names></name><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Hingorani</surname><given-names>Aroon D</given-names></name><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name><surname>Casas</surname><given-names>Juan P</given-names></name><xref rid="aff6" ref-type="aff">6</xref><xref rid="aff7" ref-type="aff">7</xref><xref ref-type="corresp" rid="cor1">&#x0002a;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Universidad Aut&#x000f3;noma de Bucaramanga, Bucaramanga, Colombia </aff><aff id="aff2"><label>2</label>Instituto de Ciencias de la Salud, Medell&#x000ed;n, Colombia </aff><aff id="aff3"><label>3</label>Universidad del Valle, Cali, Colombia </aff><aff id="aff4"><label>4</label>Universidad de Cartagena, Cartagena, Colombia </aff><aff id="aff5"><label>5</label>Universidad Industrial de Santander, Bucaramanga, Colombia </aff><aff id="aff6"><label>6</label>Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom </aff><aff id="aff7"><label>7</label>Centre for Clinical Pharmacology, Department of Medicine, at British Heart Foundation laboratories at University College London, London, United Kingdom </aff><contrib-group><contrib contrib-type="editor"><name><surname>Minelli</surname><given-names>Cosetta</given-names></name><role>Academic Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">University of Leicester, United Kingdom</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>nserrano&#x00040;unab.edu.co</email> (NCS), <email>Juan.Pablo-Casas&#x00040;lshtm.ac.uk</email> (JPC)</corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2006</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2006</year></pub-date><volume>3</volume><issue>12</issue><elocation-id>e520</elocation-id><history><date date-type="received"><day>15</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>31</day><month>10</month><year>2006</year></date></history><copyright-statement><bold>Copyright:</bold> &#x000a9; 2006 Serrano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2006</copyright-year><abstract><sec id="st1"><title>Background</title><p>Inappropriate activation of the renin&#x02013;angiotensin system may play a part in the development of preeclampsia. An insertion/deletion polymorphism within the angiotensin-I converting enzyme gene <italic>(ACE-I/D)</italic> has shown to be reliably associated with differences in angiotensin-converting enzyme (ACE) activity. However, previous studies of the <italic>ACE-I/D</italic> variant and preeclampsia have been individually underpowered to detect plausible genotypic risks.</p></sec><sec id="st2"><title>Methods and Findings</title><p>A prospective case-control study was conducted in 1,711 unrelated young pregnant women (665 preeclamptic and 1,046 healthy pregnant controls) recruited from five Colombian cities. Maternal blood was obtained to genotype for the <italic>ACE-I/D</italic> polymorphism. Crude and adjusted odds ratio (OR) and 95&#x00025; confidence interval (CI) using logistic regression models were obtained to evaluate the strength of the association between <italic>ACE-I/D</italic> variant and preeclampsia risk. A meta-analysis was then undertaken of all published studies to February 2006 evaluating the <italic>ACE-I/D</italic> variant in preeclampsia. An additive model (per-<italic>D</italic>-allele) revealed a null association between the <italic>ACE-I/D</italic> variant and preeclampsia risk (crude OR &#x0003d; 0.95 &#x0005b;95&#x00025; CI, 0.81&#x02013;1.10&#x0005d;) in the new case-control study. Similar results were obtained after adjusting for confounders (adjusted per-allele OR &#x0003d; 0.90 &#x0005b;95&#x00025; CI, 0.77&#x02013;1.06&#x0005d;) and using other genetic models of inheritance. A meta-analysis (2,596 cases and 3,828 controls from 22 studies) showed a per-allele OR of 1.26 (95&#x00025; CI, 1.07&#x02013;1.49). An analysis stratified by study size showed an attenuated OR toward the null as study size increased.</p></sec><sec id="st3"><title>Conclusions</title><p>It is highly likely that the observed small nominal increase in risk of preeclampsia associated with the <italic>ACE D</italic>-allele is due to small-study bias, similar to that observed in cardiovascular disease. Reliable assessment of the origins of preeclampsia using a genetic approach may require the establishment of a collaborating consortium to generate a dataset of adequate size.</p></sec></abstract><abstract abstract-type="toc"><p>The observed small increase in risk of preeclampsia associated with the<italic>ACE D</italic>-allele is likely to be due to small-study bias, a similar result to that observed in cardiovascular disease.</p></abstract><abstract abstract-type="editor"><sec id="sb1"><title>Editors' Summary</title><sec id="sb1a"><title>Background.</title><p>Preeclampsia is a common condition affecting pregnant women worldwide; it is defined as the presence of increased blood pressure, together with protein in the urine. Although in many women preeclampsia may never result in symptoms, other women may experience headaches, problems with their vision, swollen ankles and feet, and other problems. Sometimes, preeclampsia progresses to eclampsia, in which potentially life-threatening seizures result. The causes of preeclampsia are not well understood, but several factors are known to contribute to the risk. These factors include diabetes, high blood pressure prior to pregnancy, obesity, and first pregnancy. There is also the possibility that preeclampsia has, at least in part, a genetic basis; the condition is more likely among women whose relatives have also had it. However, no definite genetic cause has yet been confirmed.</p></sec><sec id="sb1b"><title>Why Was This Study Done?</title><p>A common variant in one particular gene, <italic>ACE,</italic> which codes for the angiotensin-1 converting enzyme, has been linked with preeclampsia in a number of different studies. The protein encoded by <italic>ACE</italic> is involved in controlling blood pressure and the balance of fluid and salts in the blood. However, many of the studies supposedly linking <italic>ACE</italic> and preeclampsia were done on very few participants. Small studies are more likely to generate &#x0201c;false positive&#x0201d; findings. Therefore, a group of investigators from Colombia and the UK wanted to find out whether they could reproduce the supposed link between the <italic>ACE</italic> gene variant and preeclampsia in a large study, and also to see whether the previous studies could have been &#x0201c;false positives.&#x0201d;</p></sec><sec id="sb1c"><title>What Did the Researchers Do and Find?</title><p>These investigators carried out a case-control study. This means that women with preeclampsia (&#x0201c;cases&#x0201d;) were recruited, and compared with women similar in all other respects but who did not have preeclampsia (&#x0201c;controls&#x0201d;). In total 1,711 pregnant women from five Colombian cities were studied, of whom 665 had preeclampsia and 1,046 did not. Blood was taken from each participant and used for DNA sequencing of the <italic>ACE</italic> gene. The investigators then did a statistical comparison to see whether there was any association between preeclampsia and possession of a particular variant of the <italic>ACE</italic> gene. The results showed that there was no such association. Then, the investigators did a literature search to find all previous studies that had examined a possible link between variants of the <italic>ACE</italic> gene and preeclampsia. They found 22 studies reporting data obtained from 6,424 women (these figures include the results from the investigators' own case-control study described here). The data from all of these studies were then put together into a combined analysis. This combined analysis did suggest a small increase in the risk of preeclampsia in women with one particular variant in the <italic>ACE</italic> gene. However, this result was more likely in studies with small numbers of participants. Furthermore, the earliest studies done were most likely to show an effect, with the supposed link disappearing as more and more data were collected.</p></sec><sec id="sb1d"><title>What Do These Findings Mean?</title><p>The findings presented here suggest that &#x0201c;small study bias&#x0201d; may explain the discrepancy between the results of the case-control study and the combined analysis. That is, studies involving few participants are less reliable and more likely to produce false-positive results. Therefore, it is possible that the proposed link between <italic>ACE</italic> gene variants and preeclampsia is a spurious one. The investigators propose that in future, collaborative research networks will be needed to carry out rigorous research on the genetics of preeclampsia. Such initiatives will help to overcome the problem of bias that can arise from small studies.</p></sec><sec id="sb1e"><title>Additional Information.</title><p>Please access these Web sites via the online version of this summary at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030520">http://dx.doi.org/10.1371/journal.pmed.0030520</ext-link>.</p><list list-type="bullet"><list-item><p>Information for patients from<ext-link ext-link-type="uri" xlink:href="http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=431"> NHS Direct (UK National Health Service)</ext-link> about preeclampsia</p></list-item><list-item><p>Medical encyclopedia entry on preeclampsia from <ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/medlineplus/ency/article/000898.htm">MedLine Plus</ext-link>, supplied by the US National Library of Medicine</p></list-item><list-item><p>Information from the World Health Organization and Pan American Health Organization on <ext-link ext-link-type="uri" xlink:href="http://www.paho.org/Project.asp?SEL=TP&#x00026;LNG=ENG&#x00026;ID=194">maternal health in the Americas</ext-link></p></list-item></list></sec></sec></abstract><counts><page-count count="13"/></counts><custom-meta-wrap><custom-meta><meta-name>citation</meta-name><meta-value>Serrano NC, D&#x000ed;az LA, P&#x000e1;ez MC, Mesa CM, Cifuentes R, et al. (2006) Angiotensin-converting enzyme insertion/deletion polymorphism and preeclampsia risk: Evidence of small-study bias. PLoS Med 3(12): e520. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pmed.0030520">10.1371/journal.pmed.0030520</ext-link></meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Preeclampsia is a maternal disease of pregnancy associated with increased blood pressure and proteinuria after 20 weeks of gestation. It is a major cause of maternal and neonatal mortality and morbidity worldwide and has particularly high incidence in Latin American and Caribbean countries, in which hypertensive disorders during pregnancy account for 25.7&#x00025; of maternal deaths &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b001">1</xref>,<xref ref-type="bibr" rid="pmed-0030520-b002">2</xref>&#x0005d;. Preeclampsia is thought to be the result of the interplay between important genetic components and environmental influences; however, the factors and the mechanisms that lead to preeclampsia remain elusive &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b003">3</xref>&#x0005d;. As a result, there is a lack of effective preventive interventions &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b004">4</xref>&#x0005d;.</p><p>With the exception of smoking, established risk factors for cardiovascular disease, including high blood pressure, diabetes, and obesity, are also risk factors for preeclampsia &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b005">5</xref>&#x0005d;. In addition, women who suffer from preeclampsia have an increased risk of later cardiovascular disease, which clearly suggests a shared aetiology &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b006">6</xref>&#x0005d;.</p><p>Inappropriate activation of the renin&#x02013;angiotensin system may play a part in the development of many cardiovascular disorders, including preeclampsia &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b007">7</xref>,<xref ref-type="bibr" rid="pmed-0030520-b008">8</xref>&#x0005d;. A common insertion/deletion polymorphism within the angiotensin-I converting enzyme gene <italic>(ACE-I/D)</italic> has been reliably associated with substantial differences in the plasma and tissue angiotensin-converting enzyme (ACE) activity in a codominant (additive) fashion not only in persons of European descent, but also in other populations such as Hispanics &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b009">9</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b011">11</xref>&#x0005d;. Individuals carrying the <italic>D</italic> allele have higher ACE activity, which has been proposed as an intermediate phenotype of potential relevance for the development of high blood pressure and subclinical atheroma (i.e., higher intima-media thickness of the carotid artery) &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b010">10</xref>,<xref ref-type="bibr" rid="pmed-0030520-b012">12</xref>&#x0005d;. Despite the biological plausibility and the consistency of the effect of the <italic>ACE-I/D</italic> polymorphism on ACE activity, associations of the <italic>ACE-I/D</italic> polymorphism and coronary heart disease, coronary artery restenosis, stroke, and renal disease have been inconsistent &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b016">16</xref>&#x0005d;. Moreover, systematic reviews and meta-analyses have indicated the presence of small-study bias in the published literature &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b016">16</xref>&#x0005d;.</p><p>Several studies, also usually small in size, have reported that women carrying the <italic>D</italic> allele of the <italic>ACE-I/D</italic> polymorphism have higher ACE activity and higher measures of uterine artery resistance, which is a marker for development of intrauterine growth retardation and preeclampsia &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b008">8</xref>,<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>&#x0005d;. These observations led to the proposal that the <italic>ACE-I/D</italic> polymorphism may be a good candidate in the search for a cause of preeclampsia. However, to date, studies evaluating the role of <italic>ACE-I/D</italic> polymorphism in preeclampsia have been individually underpowered to detect plausible genetic effect sizes, being much smaller than more recent studies in cardiovascular disease. We hypothesized that the published literature on the <italic>ACE-I/D</italic> polymorphism in preeclampsia might be similarly affected by small-study bias. To test this hypothesis, we conducted a new large genetic association study on the <italic>ACE-I/D</italic> polymorphism and preeclampsia in a geographical region with a high incidence of preeclampsia. We then set this study within the context of a systematic review and a meta-analysis of all studies conducted to date.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Case-Control Study Participants</title><p>A prospective case-control study was conducted in 1,711 unrelated young pregnant women (665 preeclamptic participants and 1,046 healthy pregnant controls) recruited from five Colombian cities at the time of delivery between January 2000 and December 2005. A verbal interview with a structured questionnaire was conducted by trained personnel at the time of the delivery to ascertain maternal age, gestational age, parity, smoking status during pregnancy, family history of preeclampsia, ethnic background, and socioeconomic position. On two separate occasions, the mean of two readings of blood pressure was obtained (four measurements in total) at the time of delivery. Blood pressure was measured in the right arm after a five-minute period of rest in a seated position using mercury sphygmomanometers or electronic devices calibrated against a mercury standard.</p><p>A case was defined as a primigravid woman younger than 26 years old with blood pressure 140/90 mm Hg or above, and proteinuria 0.3 grams or above in 24 hours, or a reading 2&#x0002b; or above on a dipstick in a random urine determination with no evidence of urinary tract infection after 20 weeks of gestation &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b018">18</xref>&#x0005d;. At least one control was recruited after each case within a window of 24 hours from the same hospital that provided the cases. A control was defined as a primigravid woman younger than 26 years old without preeclampsia and in labour after 37 weeks of pregnancy. To improve the homogeneity of the phenotype under evaluation, women with a prior history of autoimmune, metabolic (including diabetes or gestational diabetes), renal, or cardiac (including chronic hypertension) diseases were excluded from the study. All participants signed the informed consent document approved by the Ethics Committee from the Universidad Aut&#x000f3;noma de Bucaramanga, Colombia.</p><sec id="s2a1"><title>DNA extraction and genotyping.</title><p>Blood was drawn from the antecubital vein into EDTA and samples stored at &#x02212;50 &#x000b0;C for DNA extraction, using the QIAamp DNA blood mini-kit (QIAGEN, Hilden, Germany). The <italic>ACE-I/D</italic> polymorphism in intron 16 was detected according to the method described by Rigat, et al. &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b009">9</xref>&#x0005d;. PCR is known to have a tendency to preferentially amplify the short deletion <italic>(D)</italic> allele in contrast to the larger insertion <italic>(I)</italic> allele in a competitive amplification reaction when both alleles are present, as occurs in individuals with the <italic>ID</italic> genotype. This leads to mistyping of <italic>ID</italic> individuals as <italic>DD</italic> in approximately 4&#x00025;&#x02013;5&#x00025; of the samples. To avoid any mistyping of <italic>ID</italic> as <italic>DD,</italic> a second PCR amplification using insertion-specific primers was conducted for all participants who were homozygous for the <italic>D</italic> allele &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b019">19</xref>&#x0005d;. For a detailed description of the genotyping methods, see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>. All available DNA samples were genotyped and included in the present report, with no exclusions. For quality control, a random sample (<italic>n</italic> &#x0003d; 156) was subjected to a second PCR and genotyping to minimize any possible misclassification. The Cohen's kappa value among the samples regenotyped was equal to 0.95 (95&#x00025; CI &#x0005b;confidence interval&#x0005d;, 0.94&#x02013;0.96), and the error rate was 2.56&#x00025; (95&#x00025; CI, 0.70&#x02013;6.43). Genotyping was conducted blinded to the clinical status of the participants.</p></sec><sec id="s2a2"><title>Statistical analysis.</title><p>To evaluate the presence of differences between groups, unpaired Student's t-, &#x003c7;<sup>2</sup>, or Mann-Whitney tests were used as appropriate. A test for departure from Hardy-Weinberg equilibrium was performed by <italic>&#x003c7;</italic><sup>2</sup> analysis. The principal a priori hypothesis was that the association between the <italic>ACE-I/D</italic> polymorphism and preeclampsia follows an additive model according to the number of <italic>D</italic> alleles. The additive &#x0201c;per-allele&#x0201d; model (in a log-scale) was based on the effect of the <italic>ACE-I/D</italic> variant on its intermediate phenotype (ACE activity), established in large studies and overviews as being a reliable association &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b010">10</xref>&#x0005d;. However, recessive and dominant models and multiple pairwise comparisons (<italic>ID</italic> versus <italic>II</italic> and <italic>DD</italic> versus <italic>II</italic>) were also evaluated for completeness as secondary outcomes.</p><p>Multivariate analysis using logistic regression methods was also conducted to control for potential confounders (maternal age, ethnic background, place of birth of the women, recruitment centre, socioeconomic position, urinary or vaginal infections during pregnancy, and smoking status during pregnancy).</p><p>To explore the prior hypothesis that the genotypic odds ratio (OR) is greater in women with an enriched phenotype, an analysis using an additive model was repeated for women stratified according to the presence of family history of preeclampsia (positive versus negative family history in mother or sisters), and disease severity with severe preeclampsia being defined as blood pressure above 160/110 mm Hg or proteinuria of 5 grams or more in 24 hours, eclampsia, or the HELLP syndrome. For these analyses 99&#x00025; CIs were used to make some allowance for their exploratory nature. All statistical analyses were conducted using Stata, Version 9 (Stata Corporation, College Station, Texas, United States).</p></sec></sec><sec id="s2b"><title>Meta-Analysis</title><sec id="s2b1"><title>Search strategy and selection criteria.</title><p>Electronic databases (MEDLINE, EMBASE, LILACS, KoreaMed, and Google Scholar) were searched up to February 2006 for all genetic association studies evaluating the <italic>ACE-I/D</italic> polymorphism and preeclampsia in humans in all languages. The search strategy contained both medical subject heading terms and text words as follows: &#x0201c;angiotensin-converting enzyme&#x0201d; or &#x0201c;ACE&#x0201d; or &#x0201c;peptidyl-dipeptidase A,&#x0201d; in combination with &#x0201c;pre-eclampsia&#x0201d; or &#x0201c;preeclampsia&#x0201d; or &#x0201c;pregnant hypertensive disorders&#x0201d; or &#x0201c;pregnancy hypertension,&#x0201d; and combined with &#x0201c;genetic&#x0201d; or &#x0201c;polymorphism(s)&#x0201d; or &#x0201c;mutation&#x0201d; or &#x0201c;genotype&#x0201d; or &#x0201c;gene(s).&#x0201d; No limits were used in the search strategy. We searched for any additional studies in the references of all identified publications, including previous relevant meta-analyses, and used the MEDLINE option &#x0201c;related articles&#x0201d; for all the relevant papers.</p><p>For inclusion, studies had to involve unrelated women and examine the association between the <italic>ACE-I/D</italic> polymorphism and preeclampsia. Studies published as full-length articles or letters in peer-reviewed journals in any language were included, as well as abstracts taken from reference lists of identified publications. Authors were contacted (on at least three occasions) to obtain information on the genotype frequency by case-control status and by disease severity (severe and nonsevere preeclampsia), the use of blinding of genotyping staff to clinical status, the definition of outcomes, and, in a few cases, to clarify possible overlapping of study results. A positive reply was obtained in 15 out of 21 study authors contacted.</p></sec><sec id="s2b2"><title>Data extraction.</title><p>The following information was extracted (entered into databases by two of the authors, JPC and MCP) from each study and disagreements resolved by consensus: year of publication, total cases, total controls, number of individuals by each genotype, study design, source of controls, matching variable, thresholds used to define preeclampsia, country of origin, ethnicity, <italic>&#x003c7;</italic><sup>2</sup> goodness of fit for Hardy-Weinberg equilibrium and its <italic>p</italic>-value, use of blinding, mean age of participants, frequency of nulliparous women, and main exclusion criteria. In the few instances in which genotype frequencies provided by the investigators in tabular data differed slightly from published figures, the tabular data were used. Women with gestational hypertension were excluded from the present meta-analysis in order to improve the homogeneity of phenotype between studies.</p></sec><sec id="s2b3"><title>Statistical analysis.</title><p>Data were analysed using Stata 9. The genetic model to be considered as the priori hypothesis was an additive model, following the considerations previously described for the case-control study. Secondary analyses involved ORs for other genetic models of inheritance such as recessive, dominant, and pairwise comparisons of the different genotypes. For all the models used, the <italic>D</italic> allele was considered the one at risk. For the additive or per-allele model, the OR was compared between cases and controls by assigning scores for different genotype groups and calculating ORs by logistic regression. We calculated the random effect summary OR and CIs for each polymorphism. To make some allowance for multiple comparisons 99&#x00025; CIs were used for individual studies, and 95&#x00025; CIs were reserved for the combined estimates. The inverse variance-weighted method was used to calculate the summary OR &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>&#x0005d;. Heterogeneity was assessed by the DerSimonian and Laird <italic>Q</italic> test and <italic>I</italic><sup>2</sup> was used as a measure to describe the percentage of variability in point estimates that was due to heterogeneity rather than sampling error &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>&#x0005d;. Sources of between-study heterogeneity were explored using random effect metaregression models with restricted maximum likelihood estimation. The prespecified characteristics for assessment of sources of inter-study heterogeneity were: Study size (number of cases: &#x0003c;100, 100&#x02013;200, and &#x02265;200); blinding of genotyping staff (blinded, unblinded, or unknown); disease severity (severe versus nonsevere preeclampsia); ethnicity of women evaluated (of European descent, Asian, Hispanic, Afro-Caribbean, and others); preeclampsia definition (adequate versus unclear); and publication language (English&#x02013; versus non-English&#x02013;language journals). Funnel plots of the effect estimate against the sample size, Egger regression asymmetry test, and a weighted (by the inverse of the variance of the estimate) linear fixed regression of the log OR against the inverse of the sample size (linear-regression model) were used to evaluate small-study effects &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>,<xref ref-type="bibr" rid="pmed-0030520-b021">21</xref>&#x0005d;. To evaluate stability over time of the effect estimate, cumulative meta-analysis using random effect models was conducted &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b020">20</xref>&#x0005d;.</p></sec></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Case-Control Study</title><p>Clinical and demographic data of the cases and controls are shown in <xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>. There were no significant differences in maternal age, ethnic background, and socioeconomic position between cases and controls (<xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>). Expected differences in maternal blood pressure, parity, and newborn weight and condition were recorded.</p><p>The distribution of the <italic>ACE-I/D</italic> genotypes and allelic frequencies were not significantly different according to the case-control status (<xref ref-type="table" rid="pmed-0030520-t001">Table 1</xref>). Genotype frequencies according to the ethnic group and by recruitment centre are reported in &#x0201c;Appendix Table I&#x0201d; in <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>. An additive model (per-<italic>D</italic>-allele) revealed a null association between the <italic>ACE-I/D</italic> variant and preeclampsia risk (crude OR &#x0003d; 0.95 &#x0005b;95&#x00025; CI, 0.81&#x02013;1.10&#x0005d;). Adjusting for maternal age, ethnicity, recruitment centre, and place of birth, aimed to minimize the effect of possible population admixture, did not change the estimate of the effect (model-1 OR &#x0003d; 0.92 &#x0005b;95&#x00025; CI, 0.78&#x02013;1.07&#x0005d;). A similar result was obtained after further adjustment for additional potential confounders such as socioeconomic position, presence of urinary or vaginal infections during pregnancy, and smoking status during pregnancy (model-2 OR &#x0003d; 0.90 &#x0005b;95&#x00025; CI, 0.77&#x02013;1.06&#x0005d;). ORs for other genetic models of inheritance also yielded a null association (<xref ref-type="table" rid="pmed-0030520-t002">Table 2</xref>). Pre-specified exploratory subgroup analyses indicated that with the exception of family history of preeclampsia (positive-history OR &#x0003d; 1.30 &#x0005b;99&#x00025; CI, 0.75&#x02013;2.26&#x0005d; versus negative-history OR &#x0003d; 0.86 &#x0005b;99&#x00025; CI, 0.68&#x02013;1.10&#x0005d;; <italic>p</italic>-value for heterogeneity equal to 0.07), no substantial heterogeneity of the genetic effect size was observed for any of the subgroups (<xref ref-type="fig" rid="pmed-0030520-g001">Figure 1</xref>). Additionally, stratified analysis by recruitment centre according to the conformity with Hardy-Weinberg equilibrium yielded similar, null results (see &#x0201c;Appendix Table II&#x0201d; in <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref>).</p></sec><sec id="s3b"><title>Meta-Analysis</title><p>A total of 30 genetic association studies, including the present study, evaluating the <italic>ACE-I/D</italic> gene variant and preeclampsia risk were identified &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>,<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b049">49</xref>&#x0005d;. We excluded eight out of 30 studies for one or more of the following reasons: two in which duplication or partial overlapping of reported data were considered likely &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b043">43</xref>,<xref ref-type="bibr" rid="pmed-0030520-b044">44</xref>&#x0005d;; three in which the outcome evaluated was solely gestational hypertension &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b045">45</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b047">47</xref>&#x0005d;; one in which relevant data were not reported and could not be obtained from study authors &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b048">48</xref>&#x0005d;; one that only recruited women with previous preeclampsia &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b017">17</xref>&#x0005d;; and one in which the sampling frame was based on the <italic>ACE-I/D</italic> genotype &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b049">49</xref>&#x0005d;. A total of 22 genetic association studies including 2,596 cases and 3,828 controls were included in the present meta-analysis (<xref ref-type="table" rid="pmed-0030520-t301">Tables 3</xref> and <xref ref-type="table" rid="pmed-0030520-t004">4</xref>) &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b022">22</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b042">42</xref>&#x0005d;. Out of the 22 studies, nine were conducted with Asian participants, eight with participants of European descent, two with African Americans, two with more than one ethnic group, and one with South Asians.</p><p>The OR under an additive model for preeclampsia was 1.26 (95&#x00025; CI, 1.07&#x02013;1.49; <italic>p</italic> &#x0003d; 0.006) (<xref ref-type="fig" rid="pmed-0030520-g002">Figure 2</xref>). However, there was evidence of substantial between-study heterogeneity (<italic>I</italic><sup>2</sup> &#x0003d; 75.1&#x00025;, <italic>&#x003c7;<sub>21</sub></italic><sup>2</sup> &#x0003d; 84.23, <italic>p</italic><sub>Het</sub> &#x0003c; 0.0001). Study characteristics such as blinding of genotyping staff, publication language, preeclampsia definition, and disease severity explained little of the heterogeneity (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>). A stratified analysis by study size, evaluated as the number of cases in each study (&#x0003c;100, 100&#x02013;200, and &#x02265;200), showed a diminished effect as the study size increased (<italic>&#x003c7;<sub>2</sub></italic><sup>2</sup> &#x0003d; 16.95, <italic>p</italic><sub>Het</sub> &#x0003d; 0.0002) (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>). Analogous results were obtained when different cutoff points (&#x0003c; 100, 100&#x02013;500, and &#x02265; 500) for the number of cases were used (<italic>&#x003c7;<sub>2</sub></italic><sup>2</sup> &#x0003d; 18.51, <italic>p</italic><sub>Het</sub> &#x0003d; 0.00009). Similarly, stratifying by ethnicity indicated that studies conducted in Asian populations tended to have a larger ORs (<italic>&#x003c7;<sub>5</sub></italic><sup>2</sup> &#x0003d; 14.4, <italic>p</italic><sub>Het</sub> &#x0003d; 0.007). These findings might be explained by the fact that eight out of the nine studies conducted in Asian populations had fewer than 100 cases in each study. The funnel plot including all studies was asymmetric, and the Egger's test (<italic>p</italic> &#x0003d; 0.06) and the linear regression model (<italic>p</italic> &#x0003d; 0.003) suggested the presence of an excess of small studies with more positive results, predominately of studies published in non-English&#x02013;language journals (<xref ref-type="supplementary-material" rid="pmed-0030520-sg001">Figure S1</xref>; see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref> for details). A cumulative synthesis of ACE-I/D variants and preeclampsia revealed substantial instability of the genetic effect over time, with studies published between 1996 and 1997 demonstrating the most protective effect, immediately followed by studies published in 1998 and 1999 indicating the most significant results in the opposite direction. Then, the effect size is seen to attenuate gradually over time toward a null association with the accumulation of more data (<xref ref-type="supplementary-material" rid="pmed-0030520-sg002">Figure S2</xref>; see <xref ref-type="supplementary-material" rid="pmed-0030520-sd001">Protocol S1</xref> for details). Genotypic ORs under other genetic models of inheritance are outlined in <xref ref-type="table" rid="pmed-0030520-t005">Table 5</xref>.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The current meta-analysis, which includes new data from the largest case-control study to date, represents the most comprehensive evaluation of the <italic>ACE-I/D</italic> variant in preeclampsia. Although a pooled per-allele OR suggested evidence of an increase in the risk of preeclampsia of 1.26 (95&#x00025; CI, 1.07&#x02013;1.49), the robustness of this summary estimate is uncertain. First, our study found a null association of the <italic>ACE-I/D</italic> variant with preeclampsia. Moreover, there was no substantial evidence of a positive effect in any of the subgroups in the prespecified analyses. Second, the meta-analysis revealed diminishing summary risk estimate as study size increased (<xref ref-type="fig" rid="pmed-0030520-g003">Figure 3</xref>), regardless of the arbitrary cutoff points used to define the categories. This result is concordant with the results of several statistical tests used to evaluate the presence of small-study bias (Egger's test <italic>p</italic> &#x0003d; 0.06 and linear-regression model test <italic>p</italic> &#x0003d; 0.003). Furthermore, since only the published literature was included, it is possible that including unpublished studies (which more often provide evidence of negative or null effects) would have provided additional evidence of small-study bias. Taken together, these findings point to small-study bias as a potential explanation for the results observed in the meta-analysis. Discrepant findings from large and small studies are not new in the field of genetics of complex disorders &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b050">50</xref>&#x0005d;. When present, discrepancy of genetic effects sizes may be due to multiple causes such as genuine heterogeneity, data manipulation and fabrication, study quality, or publication bias. A form of publication bias relevant to the current report is within-study reporting bias. Because of the facility of measuring multiple genetic markers in a study, significant positive and negative associations (sometimes arising from multiple testing) are more likely to be published early rather than late. Results from the cumulative meta-analysis support this as one possible explanation, which has been referred to as the Proteus phenomenon &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b051">51</xref>&#x0005d;. Further evidence in support of the presence of within-study reporting bias is the fact that studies published in languages other than English, and in the Asian ethnic group, tend to have larger effects, findings consistent with other recent results &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b052">52</xref>&#x0005d;.</p><p>Publication bias is increasingly being recognized as one of the main threats to the reliability of conclusions drawn from association studies with common disease outcomes. In the setting of cardiovascular and neurological diseases, several positive gene&#x02013;disease associations, usually based on meta-analysis of small studies, have been subsequently refuted by large genetic studies &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b013">13</xref>,<xref ref-type="bibr" rid="pmed-0030520-b053">53</xref>&#x0005d;. As a result, several initiatives are now underway to help overcome problems of reporting and publication bias and to help to achieve datasets of appropriate size to detect plausible genetic effects for common disorders, which are likely to require several thousands of cases of the disease (The Wellcome Trust Case Control Consortium, <ext-link ext-link-type="uri" xlink:href="http://www.wtccc.org.uk">http://www.wtccc.org.uk</ext-link>) &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>&#x0005d;. Genetic studies in preeclampsia continue to be somewhat small in size &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b055">55</xref>,<xref ref-type="bibr" rid="pmed-0030520-b056">56</xref>&#x0005d; and are usually underpowered to detect realistic genotypic relative risks (ORs between 1.15 and 1.4) &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b014">14</xref>,<xref ref-type="bibr" rid="pmed-0030520-b057">57</xref>&#x0005d;. However, considering the low incidence of preeclampsia (2&#x00025;&#x02013;3&#x00025; in developed countries), it is highly unlikely that a single centre will be able to amass the large number of cases required, and the development of networks of interested investigators may be essential &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>&#x0005d;. Therefore, international collaborations, particularly among those countries with a high incidence of preeclampsia, may make recruitment more efficient and help to include participants with different cultural and genetic backgrounds, which can provide further insight into the aetiology of the disease both genetic and/or environmental.</p><p>Despite these obstacles, the investment in adequate resources to study the genetics of preeclampsia is an important priority. Observational studies and the randomised trials of interventions that have followed have been unsuccessful thus far in identifying causal pathways in preeclampsia amenable to preventive therapies, a clear example of which are the recently failed clinical trials using either antioxidant vitamins or calcium supplements &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b058">58</xref>&#x02013;<xref ref-type="bibr" rid="pmed-0030520-b061">61</xref>&#x0005d;. A genetic approach that is less prone to confounding and reverse causation than nongenetic observational studies, may be more likely to identify causal pathways and may help to prioritise therapeutic targets that require evaluation in large and expensive randomised clinical trials &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b062">62</xref>,<xref ref-type="bibr" rid="pmed-0030520-b063">63</xref>&#x0005d;. The challenge is in how to make better use of the genetic approach in complex diseases such as preeclampsia, in particular to overcome random errors in risk estimates from small studies as well as publication bias. A suggested approach is to establish a collaborating consortium of investigators from existing studies in genetics of preeclampsia to reduce the multiple existing problems such as: (1) inadequate selection of candidate gene variants to be evaluated, (2) biased analyses, and selective reporting of positive results; (3) to promote access to unpublished data; (4) to overcome inadequate outcome definitions; and (5) to provide guidance for developing new large studies &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b054">54</xref>&#x0005d;. Until such measures are established, it will be important for both authors and journal editors to embrace the publication of both positive and negative results from &#x0201c;well-designed case-control&#x0201d; studies to diminish the problem of publication bias &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b064">64</xref>&#x0005d;. This approach has recently become a reality for clinical trials &#x0005b;<xref ref-type="bibr" rid="pmed-0030520-b065">65</xref>&#x0005d;, and it might help in reducing the temptation of researchers to explore multiple hypotheses in subgroup analyses to obtain one finding of nominal statistical significance that might help acceptance of the paper.</p><p>Investigating the aetiology of preeclampsia, one of the main causes of maternal and neonatal mortality and morbidity worldwide, should be a health research priority. A genetic approach may indeed be useful, but large collaborative studies will also be needed.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pmed-0030520-sg001"><label>Figure S1</label><caption><title>Funnel Plot of Studies of <italic>ACE-I/D</italic> Polymorphism and Preeclampsia</title><p>ORs for outcome using a per-allele model. Studies in bold are those published in non-English-language journals.</p><p>(38 KB PPT)</p></caption><media xlink:href="pmed.0030520.sg001.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed-0030520-sg002"><label>Figure S2</label><caption><title>Cumulative Synthesis of Studies of <italic>ACE-I/D</italic> Polymorphism and Preeclampsia</title><p>OR (random effect model) for outcome using a per-allele model.</p><p>(36 KB PPT)</p></caption><media xlink:href="pmed.0030520.sg002.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed-0030520-sd001"><label>Protocol S1</label><caption><title><italic>ACE-I/D</italic> Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias</title><p>(68 KB DOC)</p></caption><media xlink:href="pmed.0030520.sd001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed-0030520-sd002"><label>Alternative Language Abstract S1</label><caption><title>Translation of the Abstract into Spanish</title><p>Translation by N. C. Serrano, Universidad Aut&#x000f3;noma de Bucaramanga, Bucaramanga, Colombia.</p><p>(25 KB DOC)</p></caption><media xlink:href="pmed.0030520.sd002.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed-0030520-sd003"><label>Alternative Language Abstract S2</label><caption><title>Translation of the Abstract into Chinese</title><p>Translation by D. Wang, Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom.</p><p>(33 KB DOC)</p></caption><media xlink:href="pmed.0030520.sd003.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><sec id="s5a"><title>Accession Numbers</title><p>The SNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>) single-nucleotide polymorphism discussed in this paper is an insertion/deletion variant (rs1799752) referenced to the <italic>ACE</italic> gene with the GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/">http://www.ncbi.nlm.nih.gov/Genbank/</ext-link>) accession number J04144.</p></sec></sec></body><back><ack><p>Thanks to Drs Hideki Watanabe, Linda Morgan, Ioannis Georgiou, Rosanna Abate, Jeong Bae Park, Fran&#x000e7;ois Rousseau, Figen Gurdol, Young Ju Kim, Huai Bai, Tsunenobu Tamura, Vanita Jain, Agnieszka Seremak-Mrozikiewicz, Vladislav S. Baranov, Adriani Oliveira Gal&#x000e3;o, and Rosemary Pegoraro, who kindly provided additional valuable information from their studies to the meta-analyses.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>ACE</term><def><p>angiotensin-converting enzyme</p></def></def-item><def-item><term><italic>ACE-I/D</italic></term><def><p>angiotensin- converting enzyme gene</p></def></def-item><def-item><term>CI</term><def><p>confidence interval</p></def></def-item><def-item><term>OR</term><def><p>odds ratio</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pmed-0030520-b001"><citation citation-type="journal"><collab>World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy</collab><year>1988</year><article-title>Geographic variation in the incidence of hypertension in pregnancy</article-title><source>Am J Obstet Gynecol</source><volume>158</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">2962500</pub-id></citation></ref><ref id="pmed-0030520-b002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>KS</given-names></name><name><surname>Wojdyla</surname><given-names>D</given-names></name><name><surname>Say</surname><given-names>L</given-names></name><name><surname>Gulmezoglu</surname><given-names>AM</given-names></name><name><surname>Van Look</surname><given-names>PF</given-names></name></person-group><year>2006</year><article-title>WHO analysis of causes of maternal death: A systematic review</article-title><source>Lancet</source><volume>367</volume><fpage>1066</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">16581405</pub-id></citation></ref><ref id="pmed-0030520-b003"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sibai</surname><given-names>B</given-names></name><name><surname>Dekker</surname><given-names>G</given-names></name><name><surname>Kupferminc</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>Pre-eclampsia</article-title><source>Lancet</source><volume>365</volume><fpage>785</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">15733721</pub-id></citation></ref><ref id="pmed-0030520-b004"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Abalos</surname><given-names>E</given-names></name><name><surname>Nardin</surname><given-names>JM</given-names></name><name><surname>Merialdi</surname><given-names>M</given-names></name><name><surname>Carroli</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>Strategies to prevent and treat preeclampsia: Evidence from randomized controlled trials</article-title><source>Semin Nephrol</source><volume>24</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">15529296</pub-id></citation></ref><ref id="pmed-0030520-b005"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duckitt</surname><given-names>K</given-names></name><name><surname>Harrington</surname><given-names>D</given-names></name></person-group><year>2005</year><article-title>Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies</article-title><source>BMJ</source><volume>330</volume><fpage>565</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">15743856</pub-id></citation></ref><ref id="pmed-0030520-b006"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>JG</given-names></name><name><surname>Vermeulen</surname><given-names>MJ</given-names></name><name><surname>Schull</surname><given-names>MJ</given-names></name><name><surname>Redelmeier</surname><given-names>DA</given-names></name></person-group><year>2005</year><article-title>Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study</article-title><source>Lancet</source><volume>366</volume><fpage>1797</fpage><lpage>1803</lpage><pub-id pub-id-type="pmid">16298217</pub-id></citation></ref><ref id="pmed-0030520-b007"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>MA</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Calhoun</surname><given-names>DA</given-names></name></person-group><year>2002</year><article-title>Drugs targeting the renin-angiotensin-aldosterone system</article-title><source>Nat Rev Drug Discov</source><volume>1</volume><fpage>621</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">12402502</pub-id></citation></ref><ref id="pmed-0030520-b008"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>DM</given-names></name></person-group><year>2006</year><article-title>The role of RAS in the pathogenesis of preeclampsia</article-title><source>Curr Hypertens Rep</source><volume>8</volume><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">16672148</pub-id></citation></ref><ref id="pmed-0030520-b009"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rigat</surname><given-names>B</given-names></name><name><surname>Hubert</surname><given-names>C</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name><name><surname>Cambien</surname><given-names>F</given-names></name><name><surname>Corvol</surname><given-names>P</given-names></name><etal/></person-group><year>1990</year><article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title><source>J Clin Invest</source><volume>86</volume><fpage>1343</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">1976655</pub-id></citation></ref><ref id="pmed-0030520-b010"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agerholm-Larsen</surname><given-names>B</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Tybjaerg-Hansen</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>20</volume><fpage>484</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">10669647</pub-id></citation></ref><ref id="pmed-0030520-b011"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kammerer</surname><given-names>CM</given-names></name><name><surname>Gouin</surname><given-names>N</given-names></name><name><surname>Samollow</surname><given-names>PB</given-names></name><name><surname>VandeBerg</surname><given-names>JF</given-names></name><name><surname>Hixson</surname><given-names>JE</given-names></name><etal/></person-group><year>2004</year><article-title>Two quantitative trait loci affect ACE activities in Mexican-Americans</article-title><source>Hypertension</source><volume>43</volume><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">14707162</pub-id></citation></ref><ref id="pmed-0030520-b012"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sayed-Tabatabaei</surname><given-names>FA</given-names></name><name><surname>Houwing-Duistermaat</surname><given-names>JJ</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name></person-group><year>2003</year><article-title>Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: A meta-analysis</article-title><source>Stroke</source><volume>34</volume><fpage>1634</fpage><lpage>1639</lpage><pub-id pub-id-type="pmid">12805498</pub-id></citation></ref><ref id="pmed-0030520-b013"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keavney</surname><given-names>B</given-names></name><name><surname>McKenzie</surname><given-names>C</given-names></name><name><surname>Parish</surname><given-names>S</given-names></name><name><surname>Palmer</surname><given-names>A</given-names></name><name><surname>Clark</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5,000 cases and 6,000 controls. International Studies of Infarct Survival (ISIS) Collaborators</article-title><source>Lancet</source><volume>355</volume><fpage>434</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">10841123</pub-id></citation></ref><ref id="pmed-0030520-b014"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Bautista</surname><given-names>LE</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls</article-title><source>Arch Neurol</source><volume>61</volume><fpage>1652</fpage><lpage>1661</lpage><pub-id pub-id-type="pmid">15534175</pub-id></citation></ref><ref id="pmed-0030520-b015"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonnici</surname><given-names>F</given-names></name><name><surname>Keavney</surname><given-names>B</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: Meta-analysis of 16 studies</article-title><source>BMJ</source><volume>325</volume><fpage>517</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">12217990</pub-id></citation></ref><ref id="pmed-0030520-b016"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>DP</given-names></name><name><surname>Tai</surname><given-names>BC</given-names></name><name><surname>Koh</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>KW</given-names></name><name><surname>Chia</surname><given-names>KS</given-names></name></person-group><year>2005</year><article-title>Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects</article-title><source>Diabetologia</source><volume>48</volume><fpage>1008</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">15830182</pub-id></citation></ref><ref id="pmed-0030520-b017"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>G</given-names></name><name><surname>Parretti</surname><given-names>E</given-names></name><name><surname>Gensini</surname><given-names>F</given-names></name><name><surname>Sticchi</surname><given-names>E</given-names></name><name><surname>Mecacci</surname><given-names>F</given-names></name><etal/></person-group><year>2003</year><article-title>Maternal-fetal flow, negative events, and preeclampsia: Role of ACE I/D polymorphism</article-title><source>Hypertension</source><volume>41</volume><fpage>932</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">12654717</pub-id></citation></ref><ref id="pmed-0030520-b018"><citation citation-type="journal"><collab>Report of the National High Blood Pressure Education Program</collab><year>2000</year><article-title>Working Group on High Blood Pressure in Pregnancy</article-title><source>Am J Obstet Gynecol</source><volume>183</volume><fpage>S1</fpage><lpage>S22</lpage></citation></ref><ref id="pmed-0030520-b019"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shanmugam</surname><given-names>V</given-names></name><name><surname>Sell</surname><given-names>KW</given-names></name><name><surname>Saha</surname><given-names>BK</given-names></name></person-group><year>1993</year><article-title>Mistyping ACE heterozygotes</article-title><source>PCR Methods Appl</source><volume>3</volume><fpage>120</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">8268786</pub-id></citation></ref><ref id="pmed-0030520-b020"><citation citation-type="other"><person-group person-group-type="editor"><name><surname>Little</surname><given-names>J</given-names></name><name><surname>Higgins</surname><given-names>JPT</given-names></name></person-group><source>The HuGENet&#x02122; HuGE Review Handbook, version 1.0</source><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.hugenet.ca">http://www.hugenet.ca</ext-link>. Accessed: 28 February 2006.</comment></citation></ref><ref id="pmed-0030520-b021"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>JL</given-names></name><name><surname>Sutton</surname><given-names>AJ</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Abrams</surname><given-names>KR</given-names></name><name><surname>Rushton</surname><given-names>L</given-names></name></person-group><year>2005</year><source>Performance of tests and adjustments for publication bias in the presence of heterogeneity: Technical report 05&#x02013;01</source><publisher-loc>Leicester, England</publisher-loc><publisher-name>Department of Health Sciences, University of Leicester</publisher-name><comment>Report Number 05&#x02013;01. pp.</comment><fpage>1</fpage><lpage>31</lpage></citation></ref><ref id="pmed-0030520-b022"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>Angiotensinogen and angiotensin-I converting enzyme gene variations in Chinese pregnancy induced hypertension</article-title><source>Hua Xi Yi Ke Da Xue Xue Bao</source><volume>33</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">12575194</pub-id></citation></ref><ref id="pmed-0030520-b023"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouba</surname><given-names>I</given-names></name><name><surname>Makrydimas</surname><given-names>G</given-names></name><name><surname>Kalaitzidis</surname><given-names>R</given-names></name><name><surname>Lolis</surname><given-names>DE</given-names></name><name><surname>Siamopoulos</surname><given-names>KC</given-names></name><etal/></person-group><year>2003</year><article-title>Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><volume>110</volume><fpage>8</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">12932862</pub-id></citation></ref><ref id="pmed-0030520-b024"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>JY</given-names></name><name><surname>Yoon</surname><given-names>HS</given-names></name><name><surname>Han</surname><given-names>SS</given-names></name><name><surname>Whang</surname><given-names>CS</given-names></name><etal/></person-group><year>2004</year><article-title>Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia</article-title><source>J Korean Med Sci</source><volume>19</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">15082899</pub-id></citation></ref><ref id="pmed-0030520-b025"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dizon-Townson</surname><given-names>D</given-names></name><name><surname>Lompe</surname><given-names>I</given-names></name><name><surname>Hastings</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>LM</given-names></name><name><surname>Varner</surname><given-names>M</given-names></name><etal/></person-group><year>1995</year><article-title>A common genetic variant of the angiotensin converting enzyme is associated with both preeclampsia and chronic hypertension &#x0005b;abstract&#x0005d;</article-title><source>Am J Obstet Gynecol</source><volume>172</volume><fpage>374</fpage></citation></ref><ref id="pmed-0030520-b026"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galao</surname><given-names>AO</given-names></name><name><surname>de Souza</surname><given-names>LH</given-names></name><name><surname>da Costa</surname><given-names>BE</given-names></name><name><surname>Scheibe</surname><given-names>RM</given-names></name><name><surname>de Figueiredo</surname><given-names>CE</given-names></name></person-group><year>2004</year><article-title>Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy</article-title><source>Am J Obstet Gynecol</source><volume>191</volume><fpage>821</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">15467548</pub-id></citation></ref><ref id="pmed-0030520-b027"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gurdol</surname><given-names>F</given-names></name><name><surname>Isbilen</surname><given-names>E</given-names></name><name><surname>Yilmaz</surname><given-names>H</given-names></name><name><surname>Isbir</surname><given-names>T</given-names></name><name><surname>Dirican</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism</article-title><source>Clin Chim Acta</source><volume>341</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">14967168</pub-id></citation></ref><ref id="pmed-0030520-b028"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heiskanen</surname><given-names>JT</given-names></name><name><surname>Pirskanen</surname><given-names>MM</given-names></name><name><surname>Hiltunen</surname><given-names>MJ</given-names></name><name><surname>Mannermaa</surname><given-names>AJ</given-names></name><name><surname>Punnonen</surname><given-names>KR</given-names></name><etal/></person-group><year>2001</year><article-title>Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia</article-title><source>Am J Obstet Gynecol</source><volume>185</volume><fpage>600</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">11568784</pub-id></citation></ref><ref id="pmed-0030520-b029"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>V</given-names></name><name><surname>Khuller</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>I</given-names></name><name><surname>Sherawat</surname><given-names>BS</given-names></name></person-group><year>2005</year><article-title>Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension</article-title><source>Acta Obstet Gynecol Scand</source><volume>84</volume><fpage>929</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">16167906</pub-id></citation></ref><ref id="pmed-0030520-b030"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Ha</surname><given-names>EH</given-names></name><etal/></person-group><year>2004</year><article-title>Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin-converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><volume>116</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15294367</pub-id></citation></ref><ref id="pmed-0030520-b031"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobashi</surname><given-names>G</given-names></name><name><surname>Hata</surname><given-names>A</given-names></name><name><surname>Shido</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><etal/></person-group><year>2005</year><article-title>Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients</article-title><source>Semin Thromb Hemost</source><volume>31</volume><fpage>346</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">16052407</pub-id></citation></ref><ref id="pmed-0030520-b032"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levesque</surname><given-names>S</given-names></name><name><surname>Moutquin</surname><given-names>JM</given-names></name><name><surname>Lindsay</surname><given-names>C</given-names></name><name><surname>Roy</surname><given-names>MC</given-names></name><name><surname>Rousseau</surname><given-names>F</given-names></name></person-group><year>2004</year><article-title>Implication of an AGT haplotype in a multigene association study with pregnancy hypertension</article-title><source>Hypertension</source><volume>43</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">14638622</pub-id></citation></ref><ref id="pmed-0030520-b033"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mingwei</surname><given-names>Z</given-names></name><name><surname>Yamping</surname><given-names>Z</given-names></name><name><surname>Wehwei</surname><given-names>Ch</given-names></name></person-group><year>1998</year><article-title>Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension</article-title><source>Chin J Obs Gynecol</source><volume>33</volume><fpage>83</fpage><lpage>85</lpage></citation></ref><ref id="pmed-0030520-b034"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>L</given-names></name><name><surname>Foster</surname><given-names>F</given-names></name><name><surname>Hayman</surname><given-names>R</given-names></name><name><surname>Crawshaw</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>PN</given-names></name><etal/></person-group><year>1999</year><article-title>Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies</article-title><source>J Hypertens</source><volume>17</volume><fpage>765</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">10459873</pub-id></citation></ref><ref id="pmed-0030520-b035"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mozgovaia</surname><given-names>EV</given-names></name><name><surname>Malysheva</surname><given-names>OV</given-names></name><name><surname>Ivashchenko</surname><given-names>TE</given-names></name><name><surname>Branov</surname><given-names>VS</given-names></name></person-group><year>2002</year><article-title>Genetic predisposition to pre-eclampsia: Polymorphism of genes involved in regulation of endothelial functions</article-title><source>Balkan J Med Genetics</source><volume>5</volume><fpage>19</fpage><lpage>26</lpage></citation></ref><ref id="pmed-0030520-b036"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>CB</given-names></name><name><surname>Rom</surname><given-names>L</given-names></name><name><surname>Moodley</surname><given-names>J</given-names></name><name><surname>Pegoraro</surname><given-names>RJ</given-names></name></person-group><year>2004</year><article-title>Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women</article-title><source>J Hypertens</source><volume>22</volume><fpage>945</fpage><lpage>948</lpage><pub-id pub-id-type="pmid">15097234</pub-id></citation></ref><ref id="pmed-0030520-b037"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>CR</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Yoon</surname><given-names>BK</given-names></name><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>JH</given-names></name><etal/></person-group><year>1997</year><article-title>A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders</article-title><source>Korean J Obstet Gynecol</source><volume>40</volume><fpage>1189</fpage><lpage>1199</lpage></citation></ref><ref id="pmed-0030520-b038"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seremak-Mrozikiewicz</surname><given-names>A</given-names></name><name><surname>Drews</surname><given-names>K</given-names></name><name><surname>Malewski</surname><given-names>Z</given-names></name><name><surname>Slomko</surname><given-names>Z</given-names></name><name><surname>Mrozikiewicz</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Polymorphic genotypes of the angiotensin-converting enzyme in severe pregnancy-induced hypertension</article-title><source>Arch Perinat Med</source><volume>6</volume><fpage>22</fpage><lpage>24</lpage></citation></ref><ref id="pmed-0030520-b039"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Johanning</surname><given-names>GL</given-names></name><name><surname>Goldenberg</surname><given-names>RL</given-names></name><name><surname>Johnston</surname><given-names>KE</given-names></name><name><surname>DuBard</surname><given-names>MB</given-names></name></person-group><year>1996</year><article-title>Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration</article-title><source>Obstet Gynecol</source><volume>88</volume><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">8841206</pub-id></citation></ref><ref id="pmed-0030520-b040"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Li</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name></person-group><year>2004</year><article-title>Relationships between polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase genes and genetic susceptibility to pregnancy-induced hypertension</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><volume>39</volume><fpage>369</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">15312318</pub-id></citation></ref><ref id="pmed-0030520-b041"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Yamakawa-Kobayashi</surname><given-names>K</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name></person-group><year>2001</year><article-title>Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes</article-title><source>Thromb Haemost</source><volume>86</volume><fpage>1594</fpage><lpage>1595</lpage><pub-id pub-id-type="pmid">11776341</pub-id></citation></ref><ref id="pmed-0030520-b042"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name></person-group><year>1999</year><article-title>Detection of insertion/deletion polymorphism of angiotensin converting enzyme gene in preeclampsia</article-title><source>Chin J Med Genet</source><volume>16</volume><fpage>29</fpage><lpage>31</lpage></citation></ref><ref id="pmed-0030520-b043"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Pang</surname><given-names>MG</given-names></name><name><surname>Park</surname><given-names>MY</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>YW</given-names></name><etal/></person-group><year>2001</year><article-title>A study on the association between angiotensinogen gene and angiotensin-converting-enzyme gene and pregnancy-induced hypertension in Korean women</article-title><source>Korean J Obstet Gynecol</source><volume>44</volume><fpage>1072</fpage><lpage>1077</lpage></citation></ref><ref id="pmed-0030520-b044"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seremak-Mrozikiewicz</surname><given-names>A</given-names></name><name><surname>Drews</surname><given-names>K</given-names></name><name><surname>Chmara</surname><given-names>E</given-names></name><name><surname>Mrozikiewicz</surname><given-names>A</given-names></name></person-group><year>2001</year><article-title>Polymorphism of gene angiotensin converting enzyme in pregnancy induced hypertension</article-title><source>Ginekol Pol</source><volume>72</volume><fpage>605</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">11599244</pub-id></citation></ref><ref id="pmed-0030520-b045"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nalogowska-Glosnicka</surname><given-names>K</given-names></name><name><surname>Lacka</surname><given-names>BI</given-names></name><name><surname>Zychma</surname><given-names>MJ</given-names></name><name><surname>Grzeszczak</surname><given-names>W</given-names></name><name><surname>Zukowska-Szczechowska</surname><given-names>E</given-names></name><etal/><collab>PIH Study Group</collab></person-group><year>2000</year><article-title>Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension</article-title><source>Med Sci Monit</source><volume>6</volume><fpage>523</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">11208365</pub-id></citation></ref><ref id="pmed-0030520-b046"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nalogowska-Glosnicka</surname><given-names>K</given-names></name><name><surname>Lacka</surname><given-names>B</given-names></name><name><surname>Zychma</surname><given-names>M</given-names></name><name><surname>Grzeszczak</surname><given-names>W</given-names></name><name><surname>Michalski</surname><given-names>B</given-names></name><etal/></person-group><year>1998</year><article-title>Lack of relationship between angiotensinogen gene m235t polymorphism and gene insertion/deletion (I/D-intron 16) and Pst I RFLP (P/M-intron 7) polymorphisms of the angiotensin I converting enzyme (ACE) gene and the development of H-gestosis. Preliminary results</article-title><source>Pol Arch Med Wewn</source><volume>100</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10085710</pub-id></citation></ref><ref id="pmed-0030520-b047"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name></person-group><year>1998</year><article-title>Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><volume>33</volume><fpage>83</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">10682425</pub-id></citation></ref><ref id="pmed-0030520-b048"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year>2001</year><article-title>Study on the relation between the angiotensin converting enzyme gene and pregnancy induced hypertension</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><volume>36</volume><fpage>15</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">11778536</pub-id></citation></ref><ref id="pmed-0030520-b049"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>G</given-names></name><name><surname>Parretti</surname><given-names>E</given-names></name><name><surname>Fatini</surname><given-names>C</given-names></name><name><surname>Riviello</surname><given-names>C</given-names></name><name><surname>Gensini</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women</article-title><source>Hypertension</source><volume>45</volume><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15557391</pub-id></citation></ref><ref id="pmed-0030520-b050"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Trikalinos</surname><given-names>TA</given-names></name><name><surname>Ntzani</surname><given-names>EE</given-names></name><name><surname>Contopoulos-Ioannidis</surname><given-names>DG</given-names></name></person-group><year>2003</year><article-title>Genetic associations in large versus small studies: An empirical assessment</article-title><source>Lancet</source><volume>361</volume><fpage>567</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">12598142</pub-id></citation></ref><ref id="pmed-0030520-b051"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Trikalinos</surname><given-names>TA</given-names></name></person-group><year>2005</year><article-title>Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials</article-title><source>J Clin Epidemiol</source><volume>58</volume><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">15878467</pub-id></citation></ref><ref id="pmed-0030520-b052"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Trikalinos</surname><given-names>TA</given-names></name><name><surname>Kavvoura</surname><given-names>FK</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name></person-group><year>2005</year><article-title>Local literature bias in genetic epidemiology: An empirical evaluation of the Chinese literature</article-title><source>PLoS Med</source><volume>2</volume><elocation-id>e334.</elocation-id><comment>doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pmed.0020334">10.1371/journal.pmed.0020334</ext-link></comment></citation></ref><ref id="pmed-0030520-b053"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>DG</given-names></name><name><surname>Abou-Sleiman</surname><given-names>PM</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Ahmadi</surname><given-names>KR</given-names></name><name><surname>Lynch</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>UCHL-1 is not a Parkinson's disease susceptibility gene</article-title><source>Ann Neurol</source><volume>59</volume><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">16450370</pub-id></citation></ref><ref id="pmed-0030520-b054"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Gwinn</surname><given-names>M</given-names></name><name><surname>Little</surname><given-names>J</given-names></name><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Bernstein</surname><given-names>JL</given-names></name><etal/><collab> Human Genome Epidemiology Network and the Network of Investigator Networks</collab></person-group><year>2006</year><article-title>A road map for efficient and reliable human genome epidemiology</article-title><source>Nat Genet</source><volume>38</volume><fpage>3</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16468121</pub-id></citation></ref><ref id="pmed-0030520-b055"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CK</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Savvidou</surname><given-names>MD</given-names></name><name><surname>Sahemey</surname><given-names>MK</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name><etal/></person-group><year>2006</year><article-title>Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: A case-control study and a meta-analysis</article-title><source>BMC Pregnancy Childbirth</source><volume>6</volume><fpage>7</fpage><pub-id pub-id-type="pmid">16542455</pub-id></citation></ref><ref id="pmed-0030520-b056"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>August</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Genetic thrombophilias and preeclampsia: A meta-analysis</article-title><source>Obstet Gynecol</source><volume>105</volume><fpage>182</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">15625161</pub-id></citation></ref><ref id="pmed-0030520-b057"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Bell</surname><given-names>JI</given-names></name></person-group><year>2001</year><article-title>Association study designs for complex diseases</article-title><source>Nat Rev Genet</source><volume>2</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">11253062</pub-id></citation></ref><ref id="pmed-0030520-b058"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rumbold</surname><given-names>AR</given-names></name><name><surname>Crowther</surname><given-names>CA</given-names></name><name><surname>Haslam</surname><given-names>RR</given-names></name><name><surname>Dekker</surname><given-names>GA</given-names></name><name><surname>Robinson</surname><given-names>JS</given-names></name><collab>ACTS Study Group</collab></person-group><year>2006</year><article-title>Vitamins C and E and the risks of preeclampsia and perinatal complications</article-title><source>N Engl J Med</source><volume>354</volume><fpage>1796</fpage><lpage>1806</lpage><pub-id pub-id-type="pmid">16641396</pub-id></citation></ref><ref id="pmed-0030520-b059"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poston</surname><given-names>L</given-names></name><name><surname>Briley</surname><given-names>AL</given-names></name><name><surname>Seed</surname><given-names>PT</given-names></name><name><surname>Kelly</surname><given-names>FJ</given-names></name><name><surname>Shennan</surname><given-names>AH</given-names></name><collab>Vitamins in Pre-eclampsia (VIP) Trial Consortium</collab></person-group><year>2006</year><article-title>Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial</article-title><source>Lancet</source><volume>367</volume><fpage>1145</fpage><lpage>1154</lpage><pub-id pub-id-type="pmid">16616557</pub-id></citation></ref><ref id="pmed-0030520-b060"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>J</given-names></name><name><surname>Abdel-Aleem</surname><given-names>H</given-names></name><name><surname>Merialdi</surname><given-names>M</given-names></name><name><surname>Mathai</surname><given-names>M</given-names></name><name><surname>Ali</surname><given-names>MM</given-names></name><etal/><collab> World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group</collab></person-group><year>2006</year><article-title>World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women</article-title><source>Am J Obstet Gynecol</source><volume>194</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">16522392</pub-id></citation></ref><ref id="pmed-0030520-b061"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>RJ</given-names></name><name><surname>Hauth</surname><given-names>JC</given-names></name><name><surname>Curet</surname><given-names>LB</given-names></name><name><surname>Sibai</surname><given-names>BM</given-names></name><name><surname>Catalano</surname><given-names>PM</given-names></name><etal/></person-group><year>1997</year><article-title>Trial of calcium to prevent preeclampsia</article-title><source>N Engl J Med</source><volume>337</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">9211675</pub-id></citation></ref><ref id="pmed-0030520-b062"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Shah</surname><given-names>T</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name></person-group><year>2006</year><article-title>Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk</article-title><source>Eur Heart J</source><volume>27</volume><fpage>1261</fpage><lpage>1263</lpage><pub-id pub-id-type="pmid">16684780</pub-id></citation></ref><ref id="pmed-0030520-b063"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hingorani</surname><given-names>A</given-names></name><name><surname>Humphries</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Nature's randomised trials</article-title><source>Lancet</source><volume>366</volume><fpage>1906</fpage><lpage>1908</lpage><pub-id pub-id-type="pmid">16325682</pub-id></citation></ref><ref id="pmed-0030520-b064"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JP</given-names></name></person-group><year>2006</year><article-title>Journals should publish all &#x0201c;null&#x0201d; results and should sparingly publish &#x0201c;positive&#x0201d; results</article-title><source>Cancer Epidemiol Biomarkers Prev</source><volume>15</volume><fpage>186</fpage><pub-id pub-id-type="pmid">16434613</pub-id></citation></ref><ref id="pmed-0030520-b065"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Veitch</surname><given-names>E</given-names></name></person-group><year>2006</year><source>Introducing PLoS Clin trials</source><volume>1</volume><elocation-id>e8.</elocation-id><comment>doi: <ext-link ext-link-type="doi" xlink:href="10.1371/journal.pctr.0010008">10.1371/journal.pctr.0010008</ext-link></comment></citation></ref><ref id="pmed-0030520-b066"><citation citation-type="journal"><year>2000</year><article-title>Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy</article-title><source>Am J Obstet Gynecol</source><volume>183</volume><fpage>S1</fpage><lpage>S22</lpage></citation></ref><ref id="pmed-0030520-b067"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>de Swiet</surname><given-names>M</given-names></name></person-group><year>1999</year><article-title>Classification of hypertension in pregnancy</article-title><source>Baillieres Best Pract Res Clin Obstet Gynaecol</source><volume>13</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">10746091</pub-id></citation></ref><ref id="pmed-0030520-b068"><citation citation-type="other"><article-title>National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy (1990)</article-title><source> Am J Obstet Gynecol</source><volume>163</volume><fpage>1691</fpage><lpage>1712</lpage></citation></ref><ref id="pmed-0030520-b069"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helewa</surname><given-names>ME</given-names></name><name><surname>Burrows</surname><given-names>RF</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Brain</surname><given-names>P</given-names></name><etal/></person-group><year>1997</year><article-title>Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy</article-title><source>Can Med Assoc J</source><volume>157</volume><fpage>715</fpage><lpage>725</lpage><pub-id pub-id-type="pmid">9307560</pub-id></citation></ref><ref id="pmed-0030520-b070"><citation citation-type="journal"><collab>Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists</collab><year>1996</year><article-title>ACOG technical bulletin. Hypertension in pregnancy. Number 219&#x02014;January 1996 (replaces number 91, February 1986)</article-title><source>Int J Gynaecol Obstet</source><volume>53</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">8735301</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="pmed-0030520-g001" position="float"><label>Figure 1</label><caption><title>Risk Association of <italic>ACE-I/D</italic> Variant with Preeclampsia in Selected Subgroups within the Current Study</title></caption><graphic xlink:href="pmed.0030520.g001"/></fig><fig id="pmed-0030520-g002" position="float"><label>Figure 2</label><caption><title>Meta-Analysis of Studies of <italic>ACE-I/D</italic> Polymorphism and Risk of Preeclampsia</title></caption><graphic xlink:href="pmed.0030520.g002"/></fig><fig id="pmed-0030520-g003" position="float"><label>Figure 3</label><caption><title>Studies of <italic>ACE-I/D</italic> Polymorphism and Risk of Preeclampsia Grouped by Study Characteristics</title></caption><graphic xlink:href="pmed.0030520.g003"/></fig><table-wrap id="pmed-0030520-t001" content-type="2col" position="float"><label>Table 1</label><caption><p>Maternal and Neonatal Characteristics of the Sample Studied</p></caption><graphic xlink:href="pmed.0030520.t001"/></table-wrap><table-wrap id="pmed-0030520-t002" content-type="1col" position="float"><label>Table 2</label><caption><p>Estimate of the Effect of the <italic>ACE-I/D</italic> Polymorphism on Preeclampsia Risk Modeled with Logistic Regression</p></caption><graphic xlink:href="pmed.0030520.t002"/></table-wrap><table-wrap id="pmed-0030520-t301" content-type="3col" position="float"><label>Table 3</label><caption><p>Characteristics of Published Studies of the Association between the <italic>ACE-I/D</italic> Polymorphism and Preeclampsia Included in the Meta-Analysis</p></caption><graphic xlink:href="pmed.0030520.t301"/></table-wrap><table-wrap id="pmed-0030520-t302" content-type="3col" position="float"><label>Table 3</label><caption><p>Extended. </p></caption><graphic xlink:href="pmed.0030520.t302"/></table-wrap><table-wrap id="pmed-0030520-t303" content-type="3col" position="float"><label>Table 3</label><caption><p>Extended. </p></caption><graphic xlink:href="pmed.0030520.t303"/></table-wrap><table-wrap id="pmed-0030520-t004" content-type="2col" position="float"><label>Table 4</label><caption><p>Characteristics of Published Studies of the Association between the <italic>ACE-I/D</italic> Polymorphism and Preeclampsia Included in the Meta-Analysis</p></caption><graphic xlink:href="pmed.0030520.t004"/></table-wrap><table-wrap id="pmed-0030520-t005" content-type="1col" position="float"><label>Table 5</label><caption><p>Genotypic ORs for Preeclampsia and the <italic>ACE-I/D</italic> Variant.</p></caption><graphic xlink:href="pmed.0030520.t005"/></table-wrap></sec><fn-group><fn id="ack1" fn-type="con"><p><bold>Author contributions.</bold> NCS, LAD, MCP, RC, AM, LS, ADH, and JPC designed the study. NCS, LAD, MCP, CMM, AM, AG, LS, and JPC analyzed the data. NCS, MCP, CMM, RC, AM, AG, and LS enrolled patients. NCS, LAD, MCP, CMM, AM, AG, LS, ADH, and JPC contributed to writing the paper. MCP genotyped the insertion/deletion within the angiotensin-converting enzyme gene and collected the data for the meta-analysis.</p></fn><fn id="n101" fn-type="financial-disclosure"><p><bold>Funding:</bold> This project was funded by a grant from Universidad Aut&#x000f3;noma de Bucaramanga (EGEN-10) awarded to NCS. LS holds a Medical Research Council Clinician Scientist Fellowship. ADH holds a British Heart Foundation Senior Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn><fn id="n102" fn-type="conflict"><p><bold>Competing Interests:</bold> University College London holds patents on the measurement of asymmetric dimethylarginine in the management of preeclampsia.</p></fn></fn-group></back></article> 